GlassScriptPhysician profile
Christopher L Sarnoski
NPI 1982614293
$16,007.85
in general payments reported to CMS, 2019-2025
11 companies · $2,421 in 2025
The $2,421 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,522 · 2020: $560 · 2021: $1,015 · 2022: $4,188 · 2023: $2,306 · 2024: $1,996 · 2025: $2,421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,569 · Travel and Lodging: $2,154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,569.27 |
| Travel and Lodging | $2,153.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $6,899.13 | 2019-2025 | Sapien 3 Ultra Resilia, Evoque, Pascal |
| Medtronic, INC. | $3,280.26 | 2021-2025 | Corevalve Evolut R, Symplicity G3 |
| Siemens Medical Solutions USA, INC. | $1,869.75 | 2022-2024 | |
| Medtronic Vascular, INC. | $1,586.78 | 2019-2020 | |
| Philips North America LLC | $805.14 | 2022-2024 | (Ao0) Igt Devices Intracardiac |
| Boston Scientific Corporation | $603.40 | 2020-2024 | |
| Shockwave Medical, INC | $361.08 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Abbott Laboratories | $252.31 | 2019-2025 | Amplatzer |
| W. L. Gore & Associates, INC. | $202.31 | 2021-2022 | |
| Biotronik INC. | $127.13 | 2019 | |
| Teleflex LLC | $20.56 | 2024 | Manta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Sarnoski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.